Reply: Efficacy of Intravesical Nadofaragene Firadenovec for Patients With Bacillus Calmette-Guérin-Unresponsive Nonmuscle-Invasive Bladder Cancer: 5-Year Follow-Up From a Phase 3 Trial.
| Autor: | Dinney CPN; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Texas., Narayan VM; Department of Urology, Emory University School of Medicine, Atlanta, Georgia. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | The Journal of urology [J Urol] 2024 Oct; Vol. 212 (4), pp. 625. Date of Electronic Publication: 2024 Jul 05. |
| DOI: | 10.1097/JU.0000000000004128 |
| Databáze: | MEDLINE |
| Externí odkaz: |
|